| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jun―16 |
BMS-CTMC-2025-461Ubiquitin as a Putative Causal Immune Orchestrator in Initial COVID-19 Severity: A Mendelian Randomization and Multi-Omics Study |
Yueyue Wang, Sirui Cai, Yubo Sun, Junqi Zhang, Jiaqi Ding, Jing Wang, Xiyang Zhang, Yuanhang Chang, Zhenchi Fang, Anqi Yue, Kun Yang, Dongbo Jiang |
| 2 |
[GO] |
2026―Mai―13 |
Selective Targeting of SARS-CoV-2 Spike Protein by Isatin-Hydrazide
Hybrids: Synergistic In vitro and Molecular Dynamics Approaches |
Saeed Ullah, Atta Ullah, Sobia Ahsan Halim, Syeda Bakhtawar Zahra, Suraj N. Mali, Oussama Abchir, Samir Chtita, Magda H. Abdellattif, Rima D. Alharthy, Mohammad Zubair, Mesaik M. Ahmed, Ajmal Khan, Ahmed Al-Harrasi, Zahid Shafiq |
| 3 |
[GO] |
2026―Mai―08 |
The Role of Glutathione Insufficiency in Immune Dysfunction and Increased Susceptibility to SARS-CoV-2 Infections in Type 2 Diabetes |
Vivian Yu, Vivian Zhong, Eashan Sharma, Kevin Babakhan Vartanian, Mohammad J. Nasiri, Vishwanath Venketaraman |
| 4 |
[GO] |
2026―Mrz―12 |
Structure-Guided Redesign of RBD-Specific Antibodies to Improve
Binding Affinity to SARS-CoV-2 Sublineages |
Cecília Luiza Pereira, Victor Hugo Oliveira de Andrade, Daniel Ferreira de Lima Neto, Carlos Roberto Prudêncio, Nilson Nicolau Junior, Jair Pereira da Cunha-Junior |
| 5 |
[GO] |
2026―Feb―01 |
Natural Product-Based Virtual Screening Identifies Potential Inhibitors of
Feline Coronavirus 3CLpro |
Zunyun Jiang, Hongyi Chen, Wang Xiong, Weihua Zhang, Yingguang Zhu, Ren kong |
| 6 |
[GO] |
2025―Jan―08 |
A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges |
Pegah Vosoughi, Seyed Morteza Naghib, Mehdi Rahmanian, M. R. Mozafari |
| 7 |
[GO] |
2024―Aug―28 |
Catalase: A Potential Pharmacologic Target for Hydrogen Peroxide in the Treatment of COVID-19 |
Aleksandr Urakov, Natalya Urakova, Aleksey Reshetnikov, Aleksey Shklyaev, Vladimir Nikolenko, Anatoly Osipov, Natalya Klyachko, Yulia Sorokina, Nikita Muhutdinov, Sergey Okovityi, Petr Shabanov |
| 8 |
[GO] |
2024―Jun―10 |
A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management |
Vishal Chavda, Dhananjay Yadav, Harisinh Parmar, Raxit Brahmbhatt, Bipin Patel, Kajal Madhwani, Meenu Jain, Minseok Song, Snehal Patel |
| 9 |
[GO] |
2024―Feb―22 |
Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19 |
Jabeena Khazir, Rakesh Kr Thakur, Sajad Ahmed, Manzoor Hussain, Sumit G. Gandhi, Sadhana Babbar, Shabir Ahmad Mir, Nusrat Shafi, Libert Brice Tonfack, Vijay Rani Rajpal, Tariq Maqbool, Bilal Ahmad Mir, Latif Ahmad Peer |
| 10 |
[GO] |
2024―Feb―06 |
Combating COVID-19 Crisis using Artificial Intelligence (AI) Based
Approach: Systematic Review |
Kavya Singh, Navjeet Kaur, Ashish Prabhu |
| 11 |
[GO] |
2023―Okt―19 |
Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza: A Perception on Combating Symptoms from COVID-19 |
Gene Chi Wai Man, Xu Zheng, Sze Wan Hung, Loucia Kit Ying Chan, Tao Zhang, Xiaoyan Chen, Kai On Chu, Ian Chung Yuen Huen, Darren Wang Yip Lui, Alfred Ding Wong, Chi Chiu Wang |
| 12 |
[GO] |
2023―Aug―30 |
Natural Products: A Potential New Hope to Defeat Post-Acute Sequelae of COVID-19 |
Shuang Zhao, Aliya Abdurehim, Yu Yuan, Tan Yang, Chao Li, Yanqing Zhang, Yaxin Li, Xiuyan Sun, Junbo Xie |
| 13 |
[GO] |
2023―Aug―25 |
A Critical Assessment of COVID-19 Genomic Vaccines |
Dima A. Sabbah, Rima Hajjo, Suhair Sunoqrot |
| 14 |
[GO] |
2023―Apr―14 |
SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research |
Edeildo Ferreira da Silva-Júnior, Weslany Souza Rocha, Peng Zhan |
| 15 |
[GO] |
2023―Mrz―28 |
Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective |
Praveen Kumar Verma, Varun Aggarwal, Ekta Bala, Pawan Kumar, Pankaj Raizada, Pardeep Singh |
| 16 |
[GO] |
2023―Feb―23 |
Investigating Biomarkers for COVID-19 Morbidity and Mortality |
Marco Fiore, Flavio Maria Ceci, Giampiero Ferraguti, Marco Lucarelli, Antonio Angeloni, Enea Bonci, Carla Petrella, Silvia Francati, Christian Barbato, Maria Grazia Di Certo, Francesca Gabanella, Francesca Gavaruzzi, Claudio Maria Mastroianni, Antonio Minni, Antonio Greco, Massimo Ralli, Mauro Ceccanti, Luigi Tarani |
| 17 |
[GO] |
2023―Jan―31 |
Contributions of Medicinal Chemistry During the Pandemic of Covid-19 |
Shampa Ghosh, Jitendra Kumar Sinha |
| 18 |
[GO] |
2023―Jan―27 |
SAR Based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against Covid-19: A Medicinal
Chemist Perspective |
Mohammad Mumtaz Alam, Anish Madan, Mansi Garg, Garvit Satija, Barkha Sharma, M Shaquiquzzaman, Mymoona Akhter, Ashif Iqubal, Mohammed Ahmed Khan, Suhel Parvez, Anwesha Das, Khursheed Ahmad Sheikh |
| 19 |
[GO] |
2022―Dez―27 |
Piezoelectric biosensors and nanomaterials-based therapeutics for coronavirus and other viruses: A Mini-review |
Rakesh Bhaskar, Madeshwaran Sekkarapatti Ramasamy, Sung Soon Han |
| 20 |
[GO] |
2022―Dez―26 |
Probing the neuro-psychological changes observed with the administration of COVID-19 Drugs |
Indranath Chatterjee, Videsha Bansal |
| 21 |
[GO] |
2022―Dez―06 |
The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area |
Zhongji Meng |
| 22 |
[GO] |
2022―Dez―06 |
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors |
Dima A. Sabbah |
| 23 |
[GO] |
2022―Dez―02 |
Repurposing of chemotherapeutics to combat COVID-19 |
Anil Kumar Saxena, Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede |
| 24 |
[GO] |
2022―Nov―04 |
Structure Based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design. |
Anusuya Shanmugam, Anbazhagan Venkattappan, M. Michael Gromiha |
| 25 |
[GO] |
2022―Okt―24 |
Exploring the targets of novel corona virus and docking-based screening of potential natural inhibitors to combat COVID-19 |
Asmita Samadder, Sisir Nandi, Rishita Dey |
| 26 |
[GO] |
2022―Okt―18 |
Therapeutic Targets and Computational Approaches on Drug Development for COVID-19 |
Anusuya Shanmugam |
| 27 |
[GO] |
2022―Okt―18 |
Effective Chemicals against Novel Coronavirus (COVID-19) in China |
Wei Liu |
| 28 |
[GO] |
2022―Okt―18 |
Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China |
Zhang Qi |
| 29 |
[GO] |
2022―Okt―18 |
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery |
Ariane Sternberg |
| 30 |
[GO] |
2022―Aug―03 |
Coronavirus Disease COVID-19: A New Threat to Public Health |
|
| 31 |
[GO] |
2022―Jul―27 |
Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview. |
Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin, Rachid Daoud, Achraf El Allali, Driss Cherqaoui |
| 32 |
[GO] |
2022―Jul―17 |
The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area |
Meng, ZJ |
| 33 |
[GO] |
2022―Jul―07 |
Therapeutics for the management of cytokine release syndrome in COVID-19 |
Shampa Ghosh, Shantanu Durgvanshi, Sung Soo Han, Rakesh Bhaskar, Jitendra Kumar Sinha |
| 34 |
[GO] |
2022―Jul―07 |
Novel Therapeutic Strategies for the Management of Neuropathology and Neuroprotection in COVID-19 |
Cindy Bandala |
| 35 |
[GO] |
2022―Mai―17 |
COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology |
Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Noemí Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, Luz Adriana Pichardo-Macías, Cindy Bandala, Saúl Gómez-Manzo |
| 36 |
[GO] |
2022―Mai―07 |
Mental disorders and poor COVID-19 prognosis: reevaluating the relationship through Ca2+/cAMP signalling |
Leandro Bueno Bergantin |
| 37 |
[GO] |
2022―Apr―27 |
A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds |
Juan A. Castillo-Garit, Yudith Cañizares-Carmenate, Hai Pham-The, Virginia Pérez-Doñate, Francisco Torrens, Facundo Pérez-Giménez |
| 38 |
[GO] |
2022―Apr―06 |
Potential Neuroprotective Effect of Cannabinoids in Covid-19 Patients. |
José Luis Cortes-Altamirano, Ariadna Yáñes-Pizaña, Samuel Reyes-Long, González-Maciel Angélica, Cindy Bandala, Herlinda Bonilla-Jaime, Alfonso Alfaro-Rodríguez |
| 39 |
[GO] |
2022―Apr―03 |
Vitamin D and its possible relationship to neuroprotection in COVID-19: evidence in the literature |
Saray Quintero-Fabián, Cindy Bandala, Luz Adriana Pichardo-Macías, Itzel Jatziri Contreras-García, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, José Arturo Martínez-Orozco, Iván Ignacio- Mejía, Noemí Cárdenas-Rodríguez |
| 40 |
[GO] |
2022―Mrz―08 |
BIBLIOMETRIC ANALYSIS: NANOTECHNOLOGY AND COVID-19 |
Claure Nain Lunardi, Fernanda Lima Subrinho, Mirella Paula de Freitas Barros, Raiane Cavalcante Lima, Ana Clara Magalhaes de Queiroz Melo, Daniela de Melo Barbosa, Luana Gouveia De Negreiros, Brenda Soares Rodrigues, Mateus Sousa Neiva, Joao Victor Ribeiro Linhares, Gabriel Farrapeira Dalla Costa, Anderson de Jesus Gomes |
| 41 |
[GO] |
2022―Mrz―04 |
HDAC inhibition as neuroprotection in COVID-19 infection |
Yudibeth Sixto-López, José Correa-Basurto |
| 42 |
[GO] |
2021―Jul―28 |
Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment |
Harekrishna Roy, Asha Gummadi, Bhabani Shankar Nayak, Sisir Nandi, Anil Kumar Saxena |
| 43 |
[GO] |
2021―Jul―19 |
Protease Inhibitors as Promising Weapons against COVID-19: Focus on Repurposing of Drugs Used to Treat HIV and HCV infections |
Luciana Jesus da Costa, Matheus Mendonça Pereira, Lívia de Souza Ramos, Thaís Pereira de Mello, Laura Nunes Silva, Marta Helena Branquinha, André Luis Souza dos Santos |
| 44 |
[GO] |
2021―Jun―19 |
Chimeric virus-like particles of universal antigen epitopes of coronavirus and phage Qβ coat protein trigger the production of neutralizing antibodies |
Yukun Guo, Ruizhen Guo, Yingxian Ma, Wenru Chang, Shengli Ming, Guoyu Yang, Yujie Guo |
| 45 |
[GO] |
2021―Jun―15 |
COVID-19 and diabetes mellitus: potential metabolic associations |
Pedro Henrique Abreu da Silva, Andressa Santos Garcia, Fábio Aguiar Alves, André Luis Souza dos Santos, Cátia Lacerda Sodré |
| 46 |
[GO] |
2021―Mai―13 |
The effect of recombinant human interferon alpha nasal drops to prevent COVID-19 pneumonia for medical staff in an epidemic area |
Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, Hai Li, Jie Luo |
| 47 |
[GO] |
2021―Mrz―31 |
Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance |
Gabriela Seabra, Roberta Ferreira Ventura Mendes, Luiz Felipe Vieira dos Santos Amorim, Ingrid Vianez Peregrino, Marta Helena Branquinha, André Luis Souza dos Santos, Ana Paula Ferreira Nunes |
| 48 |
[GO] |
2021―Jan―19 |
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery |
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong |
| 49 |
[GO] |
2020―Dez―08 |
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors |
Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong |
| 50 |
[GO] |
2020―Nov―13 |
Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses |
Arti Sharma, Kajal Kaliya, Sushil K. Maurya |
| 51 |
[GO] |
2020―Nov―03 |
Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents |
Anuraj Nayarisseri |
| 52 |
[GO] |
2020―Okt―01 |
Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic |
Mohamed Abouleish, Ali El-Keblawy, Kareem A. Mosa, Sameh S.M. Soliman |
| 53 |
[GO] |
2020―Okt―01 |
Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options |
Laura Nunes Silva, Thaís Pereira de Mello, Lívia de Souza Ramos, Marta Helena Branquinha, Maryam Roudbary, André Luis Souza dos Santos |
| 54 |
[GO] |
2020―Sep―23 |
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2 |
Satya P. Gupta |
| 55 |
[GO] |
2020―Jul―20 |
COVID-19: Small-Molecule Clinical Trials Landscape |
Leonardo L.G. Ferreira, Adriano D. Andricopulo |
| 56 |
[GO] |
2020―Jul―17 |
Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV) |
Gabriela Cristina Soares Rodrigues, Mayara dos Santos Maia, Renata Priscila Barros de Menezes, Andreza Barbosa Silva Cavalcanti, Natália Ferreira de Sousa, Érika Paiva de Moura, Alex France Messias Monteiro, Luciana Scotti, Marcus Tullius Scotti |
| 57 |
[GO] |
2020―Jul―16 |
Therapeutic targets and computational approaches on drug development for COVID-19 |
Anusuya Shanmugam, Nisha Muralidharan, D. Velmurugan, M. Michael Gromiha |
| 58 |
[GO] |
2020―Jul―04 |
Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. |
Ravina Khandelwal, Anuraj Nayarisseri, Maddala Madhavi, Chandrabose Selvaraj, Umesh Panwar, Khushboo Sharma, Tajamul Hussain, Sanjeev Kumar Singh |
| 59 |
[GO] |
2020―Mai―19 |
The Evolution of Computational Chemistry Along with Coronaviruses |
Weng Ieong Tou, Kuok Wa Tam, Hou Ng |
| 60 |
[GO] |
2020―Mai―17 |
Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery |
Ariane Sternberg, Dwight L. McKee, Cord Naujokat |
| 61 |
[GO] |
2020―Mai―12 |
COVID-19 Pandemic - Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis? |
Yogesh Kumar, Akanksha Jain |
| 62 |
[GO] |
2020―Mai―12 |
COVID-19: An Update on Clinical Trials |
Yogesh Kumar, Anil Kumar Singh, Shiv Kumar |
| 63 |
[GO] |
2020―Mai―12 |
Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China |
Zhang Qi, Yu Yu |
| 64 |
[GO] |
2020―Apr―13 |
Coronavirus Disease (COVID-19) Pandemic: A Race Against Time |
Amit Kumar Banerjee, Neelima Arora |
| 65 |
[GO] |
2020―Mrz―05 |
Effective Chemicals against Novel Coronavirus (COVID-19) in China |
Wei Liu, Hai-liang Zhu, Yongtao Duan |
| 66 |
[GO] |
2020―Mrz―05 |
Coronavirus Disease COVID-19: A New Threat to Public Health |
Sumit Kumar, Brijesh Rathi |
| 67 |
[GO] |
2020―Mrz―05 |
China Coronavirus Outbreak: All the Latest Updates |
Luciana Scotti, Marcus T. Scotti |
